Carcinoid Tumor Treatment in India

What is a Carcinoid Tumor?

Carcinoid tumour comes into the category of cancer types that grow slowly and develop in the body's neuroendocrine cells in several organs, including the lungs, gastrointestinal tract, and rectum. These tumours are broader neuroendocrine tumours (NET).

What is the Importance of Timely Treatment?

• Early diagnosis and treatment significantly improve the chances for positive treatment outcomes. GISTs are much more treatable when localised, meaning they have not spread outside to other organs. If the tumours are treated early, the chance for survival is increased and a lesser chance of recurrence.
• To Prevent Tumor Growth and Spread: An early intervention aims to prevent the tumour from getting too big or spreading (metastasising) in the body. For GISTs, early initiation of targeted therapeutic agents (e.g., Imatinib) greatly restricts the growth of the tumour and decreases the risk of metastasis.
• GISTs, if left untreated, can cause pathological conditions which may compromise life, such as bleeding, obstruction, or organ damage. Treatment early on, therefore, prevents these life-threatening complications and enhances the quality of life for the patient.
• Less Aggressive Treatment: Early-stage GISTs are often managed by methods that are less strenuous on the body, such as surgery, with fewer side effects and complications or targeted therapies. GISTs diagnosed at a later stage will require more intensive therapy, such as chemotherapy, radiotherapy, or experimental treatments.
• Better Quality of Life: Timely treatment also helps manage symptoms, be it pain, bleeding from the gastrointestinal tract, or obstruction.

What are the Common Symptoms of Carcinoid Tumor?

• Flushing
• Diarrhea
• Wheezing and Shortness of Breath
• Abdominal Pain or Discomfort
• Carcinoid Syndrome
• Heart Issues (Carcinoid Heart Disease)
• Fatigue

Types of Carcinoid Tumors:

• Gastrointestinal Carcinoid: It can be located in the small intestine, appendix, and rectum.
• Pulmonary Carcinoids: These tumours grow in the lungs, especially bronchi. It has two subtypes: typical (slow-growing) and atypical (more aggressive).
• Liver Carcinoid Tumors: Carcinoid tumours rarely arise in the liver but metastasise into this organ.
• Pancreatic Carcinoid Tumors: These tumours in the pancreas usually manifest with some degree of disequilibrium in their hormonal status.
• Ovarian Carcinoid Tumors: Such rare tumours exist on the ovaries, and in most cases, they would be identified inside a struma ovari.
• Thymic Carcinoid Tumors: Sporadic tumours occur in the thymus, sometimes accompanied by chest pain and shortness of breath.
• Urinary Tract Carcinoid Tumors: Carcinoid bladder or kidney tumours are rare.
• Skin Carcinoids: These are rare carcinoid tumours developing in the skin as small, firm nodules and are usually accompanied by carcinoid syndrome symptoms.

Causes and Risk Factors of Carcinoid Tumor

Causes

• Genetic Mutations
• Hormonal Imbalance

Risk Factors:

• Age
• Gender
• Inherited Syndromes
• Chronic Inflammation
• Family History
• Exposure to Certain Chemicals

Latest Research and Technologies in the Treatment of Carcinoid Tumor in India

The medical treatment of carcinoid tumours in India has adopted the newest research and technologies to meet worldwide clinical standards and healthcare capabilities.

• Tumour-Targeted Therapy: Recent advances have focused on targeted therapies in tumour growth therapy, while immunotherapy Pembrolizumab is under investigation for using the immune system in combating carcinoid tumours more effectively.
• Advanced Diagnostics: PET/CT scan and molecular imaging may add techniques for early diagnosis and better accuracy in carcinoid tumours. These techniques may induce small tumours and metastases that elude more conventional imaging.
• Surgical innovation: Modern, increasingly prevalent, minimally invasive laparoscopic and robotic-assisted surgeries in India have much fewer surgical complications and shorter recovery times than for gastrointestinal or liver metastasis patients.
• Clinical Trials and Research: Most leading hospitals in India are currently involved in several clinical trials looking into new treatments, including CAR-T cell therapy. Through collaborative research, work is done to improve treatment protocols and develop new therapeutic alternatives for carcinoid tumours.
• Multidisciplinary Programs: Comprehensive care involving multidisciplinary tumour boards ensures that each patient receives a treatment program individualised to his or her needs.

Carcinoid Tumor Prevention Tip:

• Regular screening: People with a family history of neuroendocrine tumours or genetic conditions should be screened regularly and have medical check-ups, which can lead to early detection of tumours and improved treatment outcomes.
• Healthy lifestyle: Eating well, working out, and avoiding tobacco and excessive alcohol are healthy choices that may help reduce the risk, including carcinoids.
• Manage chronic conditions: Try to manage inflammation with the help of your doctor, under the premise that these could reduce carcinoid tumours of the gastrointestinal tract.
• Genetic counselling: If there is a family history of carcinoid or neuroendocrine tumours, genetic counselling and testing can help identify people at risk. With early detection through regular screenings, better outcomes may arise.
• Prolonged consultation: Do not wait to consult your doctor if you experience several symptoms, such as abdominal pain of unclear origin, flushing, diarrhoea, or wheezing. If a tumour exists, an early diagnosis can equate to far greater chances of successful treatment.